Gout has historically been considered a disease of the financially rich, rich in diet, and rich in alcohol. This legacy frequently results in contemporary patients reporting that they are adjusting their diet to try and control their hyperuricaemia and gout, often deferring urate-lowering treatment to attempt this.
Dr. John Cush RheumNow
5 years 10 months ago
PsA Studies: Entheses, Ultrasound, Swollen not Tender Joints: Dr. Antoni Chan ( @synovialjoints) #ACR20
https://t.co/S6Nj9eWnTF https://t.co/qDOT2TwfHl
Dr. John Cush RheumNow
5 years 10 months ago
TNF Inhibitor Associated Infectious Risk Greatest in First 6 Months
https://t.co/fMF71rMAn8 https://t.co/mlFFb2m4UE
Dr. John Cush RheumNow
5 years 10 months ago
Dr. David Liew ( @drdavidliew) reviews abstracts #0431 on HCQ and QTc Prolongation as presented at #ACR20.
https://t.co/vbqf7UNzVY https://t.co/qBCqFqYQCo
Dr. John Cush RheumNow
5 years 10 months ago
Download our 2020 TNF Inhibitor Biosimilars worksheet.
https://t.co/whebbA3Ucv https://t.co/Bm5rgBPKkH
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed
Dr. John Cush RheumNow
5 years 10 months ago
Revisiting Day 1 of #ACR20. Watch our video on what to do with subclinical synovitis. https://t.co/ynSRjiAFPe https://t.co/XeeGohW8t5
Dr. John Cush RheumNow
5 years 10 months ago
How are RA patients doing using telemedicine/virtual care? Dr. Janet Pope ( @Janetbirdope) weighs in. #ACR20
https://t.co/YffT28OwgY https://t.co/OvpBDwkyEp
Dr. John Cush RheumNow
5 years 10 months ago
An International Panel Weighs in on RA Studies from Day 1 at #ACR20
https://t.co/T8mhuRYVbf https://t.co/pMPV4bxYGK
Dr. John Cush RheumNow
5 years 10 months ago
Six Things Rheumatologists Need to Know About COVID-19 by Dr. Rachel Tate ( @uptoTate) #ACR20
https://t.co/RUWDexA3Qc https://t.co/Psd8V60XxO
Dr. John Cush RheumNow
5 years 10 months ago
Watch our video on Psoriatic Disease with Dr. Lianne Gensler #ACR20
https://t.co/77D30OfbOJ https://t.co/vEm5bcNsRb
Dr. John Cush RheumNow
5 years 10 months ago
Have you read this article? Diagnostic Delay in Psoriatic Arthritis: What are the Consequences? by Dr. Olga Petryna ( @DrPetryna ).
https://t.co/En1UdcCuae https://t.co/wcROaTkK0O
Dr. David Liew discusses abstract #0934 - "Warfarin Use and Risk of Knee and Hip Replacements" - presented at the 2020 ACR annual meeting.
Ultrasonography has been added to the rheumatologist’s toolbox in recent years as a sensitive imaging modality in assessment of inflammatory arthritis but its relationship with tender or swollen joints is not quite clear. A large study of early, DMARD naive PsA patients shows that swollen joints, but not tender joints are associated with ultrasound power doppler synovitis.
